Literature DB >> 28298398

Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Jadwiga A Wedzicha1, Marc Miravitlles2, John R Hurst3, Peter M A Calverley4, Richard K Albert5, Antonio Anzueto6, Gerard J Criner7, Alberto Papi8, Klaus F Rabe9, David Rigau10, Pawel Sliwinski11, Thomy Tonia12, Jørgen Vestbo13, Kevin C Wilson14, Jerry A Krishnan15.   

Abstract

This document provides clinical recommendations for treatment of chronic obstructive pulmonary disease (COPD) exacerbations.Comprehensive evidence syntheses, including meta-analyses, were performed to summarise all available evidence relevant to the Task Force's questions. The evidence was appraised using the Grading of Recommendations, Assessment, Development and Evaluation approach and the results were summarised in evidence profiles. The evidence syntheses were discussed and recommendations formulated by a multidisciplinary Task Force of COPD experts.After considering the balance of desirable and undesirable consequences, quality of evidence, feasibility, and acceptability of various interventions, the Task Force made: 1) a strong recommendation for noninvasive mechanical ventilation of patients with acute or acute-on-chronic respiratory failure; 2) conditional recommendations for oral corticosteroids in outpatients, oral rather than intravenous corticosteroids in hospitalised patients, antibiotic therapy, home-based management, and the initiation of pulmonary rehabilitation within 3 weeks after hospital discharge; and 3) a conditional recommendation against the initiation of pulmonary rehabilitation during hospitalisation.The Task Force provided recommendations related to corticosteroid therapy, antibiotic therapy, noninvasive mechanical ventilation, home-based management, and early pulmonary rehabilitation in patients having a COPD exacerbation. These recommendations should be reconsidered as new evidence becomes available.
Copyright ©ERS 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28298398     DOI: 10.1183/13993003.00791-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  118 in total

1.  A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development Methodologies.

Authors:  Noah C Schoenberg; Alan F Barker; John Bernardo; Robin R Deterding; Jerrold J Ellner; Dean R Hess; Neil R MacIntyre; Fernando J Martinez; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

Review 2.  Medication Regimens for Managing COPD Exacerbations.

Authors:  Nirupama Putcha; Robert A Wise
Journal:  Respir Care       Date:  2018-06       Impact factor: 2.258

3.  Non-invasive ventilation in COPD exacerbation: how and why.

Authors:  Andrea Duca; Valentina Rosti; Anna Maria Brambilla; Roberto Cosentini
Journal:  Intern Emerg Med       Date:  2018-10-27       Impact factor: 3.397

4.  Participation in Pulmonary Rehabilitation after Hospitalization for Chronic Obstructive Pulmonary Disease among Medicare Beneficiaries.

Authors:  Kerry A Spitzer; Mihaela S Stefan; Aruna Priya; Quinn R Pack; Penelope S Pekow; Tara Lagu; Victor M Pinto-Plata; Richard L ZuWallack; Peter K Lindenauer
Journal:  Ann Am Thorac Soc       Date:  2019-01

5.  Medicaid Expansion and Mechanical Ventilation in Asthma, Chronic Obstructive Pulmonary Disease, and Heart Failure.

Authors:  Andrew J Admon; Michael W Sjoding; Sarah M Lyon; John Z Ayanian; Theodore J Iwashyna; Colin R Cooke
Journal:  Ann Am Thorac Soc       Date:  2019-07

Review 6.  Update: non-invasive ventilation in chronic obstructive pulmonary disease.

Authors:  Neeraj Mukesh Shah; Rebecca Francesca D'Cruz; Patrick B Murphy
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

7.  Quality of Care Delivered to Veterans with COPD Exacerbation and the Association with 30-Day Readmission and Death.

Authors:  Laura J Spece; Lucas M Donovan; Matthew F Griffith; Margaret P Collins; Laura C Feemster; David H Au
Journal:  COPD       Date:  2018-10       Impact factor: 2.409

Review 8.  Comprehensive care for chronic obstructive pulmonary disease.

Authors:  Fanny Wai San Ko; Ka Pang Chan; David Shu Cheong Hui
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 9.  Is positive airway pressure therapy underutilized in chronic obstructive pulmonary disease patients?

Authors:  Hrishikesh Kulkarni; Sairam Parthasarathy
Journal:  Expert Rev Respir Med       Date:  2019-02-15       Impact factor: 3.772

Review 10.  Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review.

Authors:  Winifred Ekezie; Rachael L Murray; Sanjay Agrawal; Ilze Bogdanovica; John Britton; Jo Leonardi-Bee
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.